|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.980 USD | -4.33% |
|
+0.51% | -68.92% |
Company Valuation: Plus Therapeutics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 16.13 | 10.65 | 7.915 | 6.781 | 70.4 | 28.63 | - | - |
| Change | - | -33.96% | -25.69% | -14.33% | 938.3% | -59.33% | - | - |
| Enterprise Value (EV) | 16.13 | 10.65 | 7.915 | 6.781 | 70.4 | 28.63 | 28.63 | 28.63 |
| Change | - | -33.96% | -25.69% | -14.33% | 938.3% | -59.33% | 0% | 0% |
| P/E | -0.95x | -0.41x | -0.41x | -0.59x | -44.2x | -1.01x | -1.66x | -13.6x |
| PBR | 1.5x | 1.29x | - | - | - | - | - | - |
| PEG | - | 0x | 0x | 0x | 0.4x | -0x | 0x | 0.2x |
| Capitalization / Revenue | - | 47.6x | 1.61x | 1.16x | 13.5x | 4.55x | 1.5x | 0.63x |
| EV / Revenue | - | 0x | 0x | 0x | 0x | 4.55x | 1.5x | 0.63x |
| EV / EBITDA | -0x | -0x | -0x | -0x | -0x | -1.24x | -1.7x | - |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -1.05x | -1.51x | -5.14x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -416.2 | -288.7 | -106 | -48.75 | -0.29 | -3.922 | -2.395 | -0.2933 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | - | 0.224 | 4.913 | 5.824 | 5.213 | 6.295 | 19.14 | 45.31 |
| EBITDA 1 | -11.85 | -19.09 | -12.69 | -13.42 | -13.31 | -23.1 | -16.8 | - |
| EBIT 1 | -12.49 | -19.71 | -13.32 | -14.7 | -15.3 | -27.27 | -18.95 | -5.567 |
| Net income 1 | -13.4 | -20.28 | -13.32 | -12.98 | -22.39 | -26.8 | -18.45 | -5.074 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 393.750 | 118.875 | 43.752 | 28.750 | 12.808 | 3.980 | 3.980 | 3.980 |
| Nbr of stocks (in thousands) | 41 | 89.6 | 181 | 236 | 5,497 | 6,883 | - | - |
| Announcement Date | 2/24/22 | 2/23/23 | 3/5/24 | 3/27/25 | 3/12/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.06x | - | - | - | 28.63M | |
| 33.98x | 5.95x | 18.43x | 0.97% | 48.62B | |
| -23.46x | 347.73x | -22.18x | -.--% | 39.86B | |
| 24.73x | 2.75x | 11.9x | -.--% | 33.91B | |
| 43.93x | 4.37x | 27.91x | -.--% | 32.32B | |
| 29.38x | 7.6x | 19.54x | 0.43% | 24.73B | |
| 31.89x | 5.17x | 23.57x | -.--% | 15.52B | |
| 23.77x | 2.03x | 8.91x | 1.13% | 13.63B | |
| 24.78x | 1.96x | 11.87x | -.--% | 13.41B | |
| Average | 20.88x | 47.20x | 12.49x | 0.32% | 24.67B | |
| Weighted average by Cap. | 21.86x | 66.25x | 11.02x | 0.33% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- PSTV Stock
- Valuation Plus Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
